Immune monitoring using the predictive power of immune profiles

Journal for ImmunoTherapy of Cancer

Volumn 1, Issue , 2013, Pages

  Gustafson, Michael P ^a   Lin, Yi ^a   LaPlant, Betsy ^a   Liwski, Courtney J ^a   Maas, Mary L ^a   League, Stacy C ^a   Bauer, Philippe R ^a   Abraham, Roshini S ^a   Tollefson, Matthew K ^a   Kwon, Eugene D ^a   Gastineau, Dennis A ^a   Dietz, Allan B ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biomarker; Cancer; CD14; CD4; Human; Immunity; Monocytes; Myeloid suppressor; Survival; Treg

Indexed keywords

CD14 ANTIGEN; HLA DR ANTIGEN;

ACUTE LUNG INJURY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; KIDNEY CARCINOMA; LEUKOCYTE; MONOCYTE; NONHODGKIN LYMPHOMA; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; SUPPRESSOR CELL;

EID: 84991030323     PISSN: None     EISSN: 20511426     Source Type: Journal    
DOI: 10.1186/2051-1426-1-7     Document Type: Article

References (25)

1. Davis MM: A prescription for human immunology. Immunity 2008, 29:835-838.
2. Maecker HT, McCoy JP, Nussenblatt R: Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol 2012, 12:191-200.
3. Palmer C, Diehn M, Alizadeh AA, Brown PO: Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 2006, 16:115.
4. de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V: Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 2009, 10:52.
5. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee P: Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2005, 2:e284.
6. Autissier P, Soulas C, Burdo TH, Williams KC: Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A 2010, 77:410-419.
7. Longo DM, Louie B, Putta S, et al: Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals ageand race-associated differences in immune signaling pathway activation. J Immunol 2012, 188:1717-1725.
8. Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Dietz AB: Systemic immune suppression in glioblastoma: the interplay between CD14 + HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol 2010, 12:631-644.
9. Lin Y, Gustafson MP, Bulur PA, Gastineau DA, Witzig TE, Dietz AB: Immunosuppressive CD14 + HLA-DR(low)/-monocytes in B-cell non-Hodgkin lymphoma. Blood 2011, 117:872-881.
10. Iscimen R, Cartin-Ceba R, Yilmaz M, et al: Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med 2008, 36:1518-1522.
11. Bernard GR, Artigas A, Brigham KL, et al: Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Am J Crit Care Med 1994, 20:225-232.
12. Bauer PR, Kashyap R, Abraham RS, Peikert T, Gajic O: Accuracy of waste blood measurement in critically ill patients. Intensive Care Med 2011, 37:721-722.
13. Appay V, Reynard S, Voelter V, Romero P, Speiser DE, Leyvraz S: Immunomonitoring of CD8+ T cells in whole blood versus PBMC samples. J Immunol Methods 2006, 309:192-199.
14. Contal C, O'Quigley J: An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 1999, 30:253-270.
15. Banham AH: Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol 2006, 27:541-544.
16. Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008, 8:776-787.
17. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC: Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 1996, 40(4):501-510.
18. Gustafson MP, Abraham RS, Lin Y, et al: Association of an increased frequency of CD14(+) HLA-DR(lo/neg) monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL). Br J Haematol 2012, 156:674-676.
19. Filipazzi P, Valenti R, Huber V, et al: Identification of a new subset of myeloid suppressor cells in pheripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol 2007, 25:2546-2553.
20. Walter S, Weinschenk T, Stenzl A, et al: Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 2012, 18:1254-1261.
21. Porrata LF, Inwards DJ, Ansell SM, et al: Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol Blood Marrow Transplant 2008, 14:807-816.
22. Ege H, Gertz MA, Markovic SN, et al: Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Br J Haematol 2008, 141:792-798.
23. Coventry BJ, Ashdown ML, Quinn MA, Markovic SN, Yatomi-Clarke SL, Robinson AP: CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool? J Transl Med 2009, 7:102.
24. Gfeller D, De Los Rios P, Caflisch A, Rao F: Complex network analysis of free-energy landscapes. Proc Nat Acad Sci USA 2007, 104:1817-1822.
25. Xiao W, Mindrinos MN, Seok J, et al: A genomic storm in critically injured humans. J Exp Med 2011, 208:2581-2590.